On this page you can search for older news. Choose a topic, type of news or enter your own keyword to filter out news.
The government is set to invest through the innovation authority Vinnova another SEK 96 million on Genomic Medicine Sweden (GMS), a national organisation led from Karolinska Institutet. Regions and universities are also putting up SEK 124 million, making a total of SEK 220 million that will make it possible to continue introducing precision medicine into Swedish healthcare.
Vinnova is investing in eleven innovation environments in precision health that will pave the way to more preventive, accurate healthcare with greater equity, while helping Sweden strengthen its position as a leading life science nation. Of the eleven innovation environments selected, three are at Karolinska Institutet.
Researchers from Karolinska Institutet participate in capacity building projects fincanced by Erasmus+